Skip to content

Clinical trials

Biliary Atresia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Atresia Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20171
20191
20201
20214
20222
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed4
Recruiting4
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Fudan University3
Albireo, an Ipsen Company2
Tongji Hospital2
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine2
Intercept Pharmaceuticals1
Mirum Pharmaceuticals, Inc.1
Nanjing Children's Hospital1
RenJi Hospital1
The Children's Hospital of Zhejiang University School of Medicine1
Tianjin First Central Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Atresia18
Cholangitis3
Bile Duct Diseases1
Biliary Tract Diseases1
Carcinoma, Hepatocellular1
Cholangitis, Sclerosing1
Choledochal Cyst1
Congenital Abnormalities1
Digestive System Diseases1
Fibrosis1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.